Amniotic Membrane Therapy in Ocular Surface Disease: Introduction

Main Article Content

Nicholas Colatrella


Amniotic Membrane Therapy, Ocular Surface Disease


The goal of this publication is to show the many uses for AMs in treating ocular surface disease and to provide a resource for their use in clinical practice.


Download data is not yet available.
Abstract 390 | pdf Downloads 241


1. Aragona P, Rolando M. Towards a dynamic customised therapy for ocular surface dysfunctions. Br J Ophthalmol 2013;97:955–60.
2. Rolando M, Zierhut M. The ocular surface and tear film and their dysfunction in dry eye disease. Surv Ophthalmol 2001;45(Suppl. 2):S203–10.
3. Baudouin C, Aragona P, Messmer EM, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul. Surf 2013;11:246–58.
4. Muri M, Moshirfar M. Birdsong O. 2018. Amniotic membrane extract and eye drops: a review of literature and clinical application, Clin Ophthalmol 2018;12:1105–12.